General Information of the Compound
Compound ID
CP0244579
Compound Name
5-benzyl-N-[(3S)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-1H-1,2,4-triazole-3-carboxamide
    Show/Hide
Synonyms
(S)-5-benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)-1H-1,2,4-triazole-3-carboxamide
1622848-92-3
3-Benzyl-N-[(3s)-5-Methyl-4-Oxo-2,3,4,5-Tetrahydr
5-benzyl-N-[(3S)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-1H-1,2,4-triazole-3-carboxamide
AC-29894
ACN-041458
AKOS030528033
AS-35128
CS-6899
GSK 2982772
GSK-2982772
GSK2982772
GTPL9554
HY-101760
J3.650.802G
LYPAFUINURXJSG-AWEZNQCLSA-N
MolPort-044-830-634
SCHEMBL15956219
T5W3M0VO9B
UNII-T5W3M0VO9B
compound 5 [PMID: 28151659]
s8484
    Show/Hide
Structure
Formula
C20H19N5O3
Molecular Weight
377.404
Canonical SMILES
CN1c2ccccc2OC[C@H](NC(=O)c2n[nH]c(Cc3ccccc3)n2)C1=O
    Show/Hide
InChI
InChI=1S/C20H19N5O3/c1-25-15-9-5-6-10-16(15)28-12-14(20(25)27)21-19(26)18-22-17(23-24-18)11-13-7-3-2-4-8-13/h2-10,14H,11-12H2,1H3,(H,21,26)(H,22,23,24)/t14-/m0/s1
    Show/Hide
InChIKey
LYPAFUINURXJSG-AWEZNQCLSA-N
CAS
1622848-92-3
Physicochemical Property
logP
1.5493
Rotatable Bonds
4
Heavy Atom Count
28
Polar Areas
100.21
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
5
Complexity
28

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 77108121
ChEMBL ID
CHEMBL4071864
DrugBank ID
DB16875
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00954, Receptor-interacting serine/threonine-protein kinase 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000100 U-937 Homo sapiens (Human)  3
1
IC50 = 1 nM
   TI
   LI
   LO
   TS
2
IC50 = 6.3 nM
   TI
   LI
   LO
   TS
3
IC50 = 16 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 0.4 nM
2 IC50 = 0.5 nM
3 IC50 = 1 nM
4 IC50 = 1.6 nM
5 IC50 = 2 nM
6 IC50 = 33 nM
Protein ID: PT05510, Receptor-interacting serine/threonine-protein kinase 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000309 NCTC clone 929 Mus musculus (Mouse)  1
1
IC50 = 1300 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( GSK2982772 )
Drug Name GSK2982772
Company GlaxoSmithKline Research Triangle Park, NC
Indication
Plaque psoriasis
Phase 2
Psoriasis vulgaris
Phase 1
Rheumatoid arthritis
Phase 1
Ulcerative colitis
Phase 1
Target(s)
Receptor-interacting protein 1 (RIPK1)
Inhibitor